HOME >> BIOLOGY >> NEWS
OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions

San Francisco, Calif. Aug. 23, 2004 To most people in the developed world, diarrhea is a nuisance. It means some discomfort and maybe a trip to the local pharmacy. However, many would be shocked to learn that it is one of the leading causes of death among the developing world's children, responsible for approximately two million deaths each year. Even more shocking, diarrhea contributes to the death of four to six million people of all ages every year around the globe.

The Institute for OneWorld Health, the first nonprofit pharmaceutical in the U.S., is working to solve this problem. OneWorld Health is conducting a landscape analysis in the field of infectious diarrhea. As a first step, OneWorld Health will use the findings from a recently held workshop of experts to examine the feasibility of an international diarrheal vaccine effort, with particular emphasis on pediatric solutions.

The group explored the state of vaccine- and diarrheal-disease research, clinical, regulatory, and legal issues, and health economics. Vaccines against the viral- and bacterial-causing agents represent one of the greatest hopes for near-term solutions for the second largest killer of children under the age of five years. In the following months, OneWorld Health will conduct follow-up meetings, issue reports and present findings to gauge international interest and potential research and development paths.

"This neglected disease area is devastating, not only because one in 200 children who contract infectious diarrhea will die from it, but for those who survive, it has a lifelong, generation-wide impact," stated Victoria Hale, Founder and CEO of OneWorld Health. She added that of all childhood infectious diseases, diarrhea is thought to have the greatest impact on fitness, cognitive function, and school performance. "We will find ways to change this, through the development of new treatments for the world's most vulnerable infants and children," Dr. Ha
'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700
Institute for OneWorld Health
23-Aug-2004


Page: 1 2

Related biology news :

1. Institute for OneWorld Health nominated for the 2004 World Technology Awards
2. Institute for OneWorld Health receives Gates Foundation grant
3. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO
4. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
5. OneWorld Health completes enrollment, treatment in Phase III India trial
6. Institute for OneWorld Health CEO advocates focus first on developing world markets
7. OneWorld Health plans to form network of volunteer pharmaceutical scientists for global health
8. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
9. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
10. Health of worlds sea lions the focus of Wakefield Symposium
11. Healthy fats and oils essential to satisfy calorie-conscious consumers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2019)... ... ... Mount Sinai researchers have discovered how the enzyme DNA polymerase delta works to ... a study published in Nature Structural & Molecular Biology, the team also reported how ... diseases. , “DNA polymerase delta serves as the duplicating machine for the millions to ...
(Date:9/30/2019)... ... September 30, 2019 , ... USDM Life Sciences ... life science organizations to accelerate innovation and maximize productivity, announces that David Blewitt ... What: Just 30 days to 21 CFR Part 11 compliance with Box, When: ...
(Date:9/25/2019)... ... September 25, 2019 , ... Modality Solutions, a ... on Inc. Magazine’s annual Inc. 5000 list, the most prestigious ranking of the ... Based on this growth, the Houston-based firm also ranked No. 47 in its ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... BOSTON (PRWEB) , ... October 03, 2019 , ... Yesterday, ... 2-3, Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important ... To an attendee audience including both developers and suppliers of clinical trials, in ...
(Date:9/24/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), ... clinical trial sites and physician investigators. The clinical trial sites are now ... Clinical trial sites are currently located in San Diego and Los Angeles California, ...
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, was ... months old, Tucker was limping and lame on his right hip and elbow. At ... it was called “the worst case the vet had seen.” He was prescribed pain ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global Healthcare Innovation ... Biotech Week Boston, a forum organized by MyBioGate, Inc. and CUBIO Innovation Center ... a careful process of evaluation, twelve companies out of over 200 applications were ...
Breaking Biology Technology:
Cached News: